Materials And Products Tenders

Amgros I/S (Amgros) is a partnership with the 5 regions as stakeholders. Amgros wants to enter into framework agreements for the drugs set out in the individual sub -contracts below, in order to supply stakeholders' hospital pharmacies with medicines and possibly resale to the Faroe Islands andGreenland. Amgros resell the medicines to the hospital pharmacies at Amgros' purchase price with a supplement. The framework agreements are non-exclusive. The framework agreements are concluded without purchase obligation and the hospital pharmacies in the regions are not required to use Amgros' framework agreements.
Tender number 1
The tender number(the sub-contract) includes the following drugs: ATC Code: B01AC04 . Generic Name: Clopidogrel . Dispensing Form: Tablets . Strength: 75 mg . Packing: 25-30 pcs . Unit Value: 75 mg . Quantity in Units: 180.Tender numbers. A supplier can thus choose to offer one, more or all tendering numbers, and allocation is done separately for each tender number. A supplier can thus be assigned one, more or all sub -contracts. Reference is made to the tender terms including the submission of tender underThe individual tender numbers.
Under the term "Quantity in units" above, an estimated consumption of the medicines is indicated under the tender number, but the real consumption may differ significantly from there. This is what the suppliers must expect. The reason for this is that there are medicines for patient treatment on theof...

The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient icatibant (ATC: B06AC02) as part of a so-called "open house model". Under the specification of uniform contractual conditions and a uniformAccess procedure is offered to all suitable and interested pharmaceutical companies or communities of pharmaceutical companies to the conclusion or accession to a discount contract in accordance with Section 130a (8) SGB V for the aforementioned active ingredients or drugs. Interested pharmaceuticalCompanies can request the participation documents and the respective contract at the contact address mentioned. The prerequisite for the conclusion of a contract is that the interested pharmaceutical company fully filled out the requested participation documents andsigned.
Medicines with the active ingredient icatibant (ATC: B06AC02)
conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for ready-made drugs with the active ingredient icatibant (ATC: B06AC02) with any time as part of a so-called "open-house model".A contract is concluded with every pharmaceutical company that meets the prerequisites for participation. There is no exclusivity. The accession or conclusion of the contract can take place at any time and on the same conditions. Individual contract negotiations are notdur...

The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient combination Tamsulosin and Dutasteride (ATC: G04CA52) as part of a so-called "open house model". Under the specification of uniform contractual termsAs well as a uniform access procedure, all suitable and interested pharmaceutical companies or communities of pharmaceutical companies are offered the conclusion or accession to a discount contract according to § 130a (8) SGB V for the aforementioned active substances or drugs.Interested pharmaceutical companies can request the participation documents and the respective contract at the contact address mentioned. The prerequisite for the conclusion of a contract is that the interested pharmaceutical company fullyFilled and signed.Final possibility in the context of a so-called "open house model". A contract is concluded with every pharmaceutical company that meets the prerequisites for participation. There is no exclusivity. The accession or the contract can be concluded at any time and to theg...

Purchase shawl
shawl

doc title: scarves

contract type: Supplies

Amgros I/S (Amgros) is a partnership with the 5 regions as stakeholders. Amgros wants to enter into framework agreements for the drugs set out in the individual sub -contracts below, in order to supply stakeholders' hospital pharmacies with medicines and possibly resale to the Faroe Islands andGreenland. Amgros resell the medicines to the hospital pharmacies at Amgros' purchase price with a supplement. The framework agreements are non-exclusive. The framework agreements are concluded without purchase obligation and the hospital pharmacies in the regions are not required to use Amgros' framework agreements.
Tender number 1
The tender number(the sub -contract) includes the following drugs: ATC Code: C03AB01 . Generic Name: Bengroflumethiazide and Potassium . Dispensing Form: Tablets . Strength: 1.25 +573 mg . Package: 100 pcs . Unit value: 2.5 mg . Quantity in units: 255850.Regardless of the other tender numbers. A supplier can thus choose to offer one, more or all tendering numbers, and allocation is done separately for each tender number. A supplier can thus be assigned one, more or all sub -contracts. Reference is made to the tender conditions including whetherSubmitting tenders under the individual tender numbers.
Under the term "Quantity in units" above, an estimated consumption of the medicines is indicated under the tender number, but the real consumption may differ significantly from there. This is what the suppliers must expect. The reason for this is that there are medicinesto ...

The subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8) SGB V for finished medicinal products with the active ingredient Aripiprazole (ATC: N05AX12-for the parenteral application) as part of a so-called "open house model". Under the specification of uniformContract conditions as well as a uniform access procedure will be completed by all suitable and interested pharmaceutical companies or communities of pharmaceutical companies to a discount contract in accordance with Section 130a (8) SGB V for the aforementioned active ingredients orMedicines offered. Interested pharmaceutical companies can request the participation documents and the respective contract at the contact address mentioned. The prerequisite for the conclusion of a contract is that interested pharmaceutical companies are the requestedParticipation documents fully filled out and signed.the parenteral application) with any time as part of a so-called "open house model". A contract is concluded with every pharmaceutical company that meets the prerequisites for participation. There is no exclusivity. The accession or the conclusion of the contract...

LOCATION OF NEW WATER NETWORK AND WORK NETWORK WORKS IN EYDAP WATER NETWORK AREA SA SERVICE A 'SECTION OF ATHENS
E-918.2
LOCATION OF NEW PRODUCTS ANDWATER NETWORK WORKS IN EYDAP WATER NETWORK APPLICATIONS SA SERVICE B 'PIRAEUS SECTION AND WESTERN ATTICA SECTION
E-918.3 SERVICE CARETitle: Ε-918

Contract Type: works

Amgros I/S (Amgros) is a partnership with the 5 regions as stakeholders. Amgros wants to enter into framework agreements for the drugs set out in the individual sub -contracts below, in order to supply stakeholders' hospital pharmacies with medicines and possibly resale to the Faroe Islands andGreenland. Amgros resell the medicines to the hospital pharmacies at Amgros' purchase price with a supplement. The framework agreements are non-exclusive. The framework agreements are concluded without purchase obligation and the hospital pharmacies in the regions are not required to use Amgros' framework agreements.
Tender number 1
The tender number(the sub -contract) includes the following drugs: ATC Code: R03AC02 . Generic Name: Salbutamol (Diskos) . Dispensing Form: Inhalation Powder . Strength: 0.2 mg . Unit Value: 0.8 mg . Quantity in Units: 87555.Tender numbers. A supplier can thus choose to offer one, more or all tendering numbers, and allocation is done separately for each tender number. A supplier can thus be assigned one, more or all sub -contracts. Reference is made to the tender terms including the submission of tender underThe individual tender numbers.
Under the term "Quantity in units" above, an estimated consumption of the medicines is indicated under the tender number, but the real consumption may differ significantly from there. This is what the suppliers must expect. The reason for this is that there are medicines for patient treatment on theoff...

The contracting authority has drawn up this tender guide to select a contractor who is-in short-capable of permit applications (including all underlying investigations) and permissions with regard to the environment, nature and construction for the CO2 collection installation in Dordrechtto take care of and to be licensed.
Permit application CO2 HVC Dordrecht

DOC title: Permit application CO2 HVC Dordrecht

Contract type:services

Exploitation of the Armentieres treatment plant
exploitation of the Armentieres treatment plant.
This consultation concerns the operation and maintenance of the Armentieres treatment plant, with a capacity of 65,000 inhabitants equivalents (EH), SISISE of the two bridges - TheBIZET - 7782 Ploegsteert -Comines Belgium.
This market is broken down into slices. It includes a firm tranche and an optional tranche n 1.
The duration of the firm tranche is 8 years from 01/01/2026 (or from the date of notification of the market to the holder, worth starting the trancheFarm, if it is posterior).
The duration of the optional tranche is 2 years at the end of the firm tranche.

Doc title: operation of the Armentieres treatment plant

Type contract:services